Navigating the Landscape: GLP-1 Receptor Agonist Availability in GermanyIn the last few years, the pharmaceutical landscape has been changed by a class of medications called GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally established to treat Type 2 diabetes, these medications have gotten worldwide attention for their considerable efficacy in chronic weight
